Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950103-03-001814
Filing Date
2003-09-05
Accepted
2003-09-05 10:36:17
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 sep0303_10ka.txt 10-K/A 501149
3 sep0303_ex1011.txt EX-10.11 54688
4 sep0303_ex1012.txt EX-10.12 54348
5 sep0303_ex21.txt EX-21 1660
6 sep0303_ex2301.txt EX-23.1 844
7 sep0303_ex2302.txt EX-23.2 1371
8 sep0303_ex9901.txt EX-99.1 2214
9 sep0303_ex9902.txt EX-99.2 2208
  Complete submission text file 0000950103-03-001814.txt   620635
Mailing Address HAMPSHIRE INTL BUSINESS PARK CHINEHAM BASINGSTOKE HAMPSHIRE ENGLAND RG X0
Business Address HAMPSHIRE INTL BUSINESS PARK CHINEHAM BASINGSTOKE HAMPSHIRE ENGLAND RG X0 1264333455
SHIRE PHARMACEUTICALS GROUP PLC (Filer) CIK: 0000936402 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-29630 | Film No.: 03882824
SIC: 2834 Pharmaceutical Preparations